Tandem Diabetes Care TNDM has achieved a significant milestone by gaining approval for the use of its t:slim X2 insulin pump with Eli Lilly’s ultra-rapid acting insulin, Lyumjev, in the European ...

The Tandem Mobi is claimed to be the world's smallest durable automated insulin delivery system ... less than half the size of the t:slim X2 pump, offers users unprecedented convenience, fitting ...

Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...

Tandem Diabetes Care has claimed approval ... delivery systems in development at Eli Lilly – and its own t:slim X2 insulin pump which was approved as an interoperable ACE device in February.

MARKHAM, Ontario, December 10, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada, ...

Both deals are integrating TypeZero's inControl platform into each company's respective devices: the Tandem t:slim insulin pump and Cellnovo's self-titled CGM system. The inControl system is also ...

The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

Park Avenue Securities LLC boosted its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 34.5% in the 4th ...